Cytokines as Therapeutic Agents and Targets in Heart Disease
Cytokine and Growth Factor Reviews 2018
Arita Dubņika, Martin A.C. Manoukian, M.Rezaa Mohammadi, Mansi Bharat Parekh, Abhijit Achyut Gurjarpadhye, Mohammed Inayathullah, Viktors Dubņiks, Jonathan R.T. Lakey, Jayakumar Rajadas

Cytokine therapies have emerged during the past decade as promising noninvasive treatments for heart disease. In general, current drug treatments are directed towards symptom control and prevention of disease progression; however, many agents also produce cause side effects that alter quality of life. Cytokine based therapies have the potential to reduce post-infarct heart failure and chronic ischemia by stimulating the proliferation and differentiation of endothelial cells and bone marrow hematopoietic stem cells and mobilizing these cells toward ischemic tissue. In turn, these mobilized cell populations contribute to myocardial regeneration. In contrast, over-expression of several cytokines has been linked to a variety of heart diseases; thus, therapies targeting and monitoring these cytokines are of great interest. Here we summarize results from clinical studies on cytokines as therapeutic agents or therapeutic targets in the treatment for heart disease as well as cytokines involved in the evolution of heart disease.

Atslēgas vārdi
Cytokine therapies, Ischemia, Myocardial infarction, Therapeutic cytokines

Dubņika, A., Manoukian, M., Mohammadi, M., Bharat Parekh, M., Achyut Gurjarpadhye, A., Inayathullah, M., Dubņiks, V., Lakey, J., Rajadas, J. Cytokines as Therapeutic Agents and Targets in Heart Disease. Cytokine and Growth Factor Reviews, 2018, Vol. 43, No. 1, 54.-68.lpp. ISSN 1359-6101. Pieejams: doi:10.1016/j.cytogfr.2018.08.003

Publikācijas valoda
English (en)
RTU Zinātniskā bibliotēka.
E-pasts:; Tālr: +371 28399196